Makena Articles
K-V Pharma renegotiates Makena deal in survival struggle
12 December 2012
US FDA approves KV Thera/Ther-Rx’ Makena, first drug to reduce risk of preterm birth in at-risk pregnant women
7 February 2011
Showing 1-2 of 2 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
